| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman | Chief Executive Officer
2 companies
Scott D. Grimes last filed a Form 4 in November 2022, as Director at CDLX. The filings on record cover 2 companies.
Historically, Scott D. Grimes's trades have earned a strong insider score of 89/100 across 46 rated trades. Over a 12-month horizon, 95.7% of those trades were profitable, with an average 12-month return of +73.5%.
At the last filing, the largest reported position was 248,779 shares of CDLX. The CDLX filings lean toward selling, a net 875,579 shares.
Scott D. Grimes has 112 Form 4 filings on record from February 2018 to November 2022, across 2 companies: Director at Cardlytics (CDLX), 2018–2022; Director at Evergy (EVRG), 2018–2020.
The 375 reported transactions were 334 open-market sales, 18 option exercises, 17 option or other derivative awards and 2 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $34K and 97 sales worth about $45.7M.
The only open-market purchase was 2,600 shares of CDLX at an average $13.00 on February 13, 2018, about $34K.
The largest open-market sale was 250,000 shares of CDLX at an average $32.30 on September 13, 2019, about $8.1M.
Shares as reported in the last Form 4 for each company; the most recent is from November 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2022 | CDLX Cardlytics, Inc. | Director | Sell | 6 | $3.92 | $23.52 | - | +89.5% | +235.5% | |
| Nov 8, 2022 | CDLX Cardlytics, Inc. | Director | Sell | 9,496 | $4.30 | $40,857.23 | -3.7% | +89.5% | +235.5% | |
| Aug 5, 2022 | CDLX Cardlytics, Inc. | Director | Sell | 9,257 | $15.19 | $140,613.83 | -3.7% | -62.6% | -6.0% | |
| May 5, 2022 | CDLX Cardlytics, Inc. | Director | Sell | 15,734 | $34.39 | $541,047.40 | -6.5% | -53.0% | -82.4% | |
| Apr 19, 2022 | CDLX Cardlytics, Inc. | Director | Sell | 4,098 | $50.09 | $205,268.82 | -1.7% | -72.4% | -84.7% | |
| Apr 4, 2022 | CDLX Cardlytics, Inc. | Director | Sale+OE | 6,000 | $57.03 | $342,176.00 | -2.6% | -59.3% | -89.2% | |
| Mar 18, 2022 | CDLX Cardlytics, Inc. | Director | Sell | 6,000 | $54.04 | $324,224.00 | -2.7% | -59.7% | -94.2% | |
| Mar 3, 2022 | CDLX Cardlytics, Inc. | Director | Sell | 6,000 | $58.28 | $349,703.46 | -2.7% | -54.4% | -91.1% | |
| Feb 18, 2022 | CDLX Cardlytics, Inc. | Director | Sell | 6,000 | $58.47 | $350,818.34 | -2.6% | -49.5% | -88.7% | |
| Feb 3, 2022 | CDLX Cardlytics, Inc. | Director | Sell | 6,000 | $63.83 | $383,009.78 | -2.5% | -39.4% | -86.8% |